Nanomaterials for reducing amyloid cytotoxicity

Chen Wang, Min Zhang, Xiaobo Mao, Yue Yu, Chen Xuan Wang, Yan Lian Yang

Research output: Contribution to journalReview article

Abstract

This review is intended to reflect the recent progress on therapeutic applications of nanomaterials in amyloid diseases. The progress on anti-amyloid functions of various nanomaterials including inorganic nanoparticles, polymeric nanoparticles, carbon nanomaterials and biomolecular aggregates, is reviewed and discussed. The main functionalization strategies for general nanoparticle modifications are reviewed for potential applications of targeted therapeutics. The interaction mechanisms between amyloid peptides and nanomaterials are discussed from the perspectives of dominant interactions and kinetics. The encapsulation of anti-amyloid drugs, targeted drug delivery, controlled drug release and drug delivery crossing blood brain barrier by application of nanomaterials would also improve the therapeutics of amyloid diseases. This review highlights the recent progress on therapeutic applications of nanomaterials in amyloid diseases. Nanomaterials as potential anti-amyloid drugs and drug delivery systems for currently available molecules are reviewed and the interaction mechanism between amyloid peptides and various nanomaterials is also discussed.

Original languageEnglish (US)
Pages (from-to)3780-3801
Number of pages22
JournalAdvanced Materials
Volume25
Issue number28
DOIs
StatePublished - Jul 26 2013
Externally publishedYes

Fingerprint

Cytotoxicity
Amyloid
Nanostructured materials
Nanoparticles
Peptides
Pharmaceutical Preparations
Drug delivery
Encapsulation
Carbon
Molecules
Kinetics

Keywords

  • aggregation
  • amyloid
  • cytotoxicity
  • inhibitor
  • nanomaterials

ASJC Scopus subject areas

  • Materials Science(all)
  • Mechanics of Materials
  • Mechanical Engineering

Cite this

Wang, C., Zhang, M., Mao, X., Yu, Y., Wang, C. X., & Yang, Y. L. (2013). Nanomaterials for reducing amyloid cytotoxicity. Advanced Materials, 25(28), 3780-3801. https://doi.org/10.1002/adma.201301210

Nanomaterials for reducing amyloid cytotoxicity. / Wang, Chen; Zhang, Min; Mao, Xiaobo; Yu, Yue; Wang, Chen Xuan; Yang, Yan Lian.

In: Advanced Materials, Vol. 25, No. 28, 26.07.2013, p. 3780-3801.

Research output: Contribution to journalReview article

Wang, C, Zhang, M, Mao, X, Yu, Y, Wang, CX & Yang, YL 2013, 'Nanomaterials for reducing amyloid cytotoxicity', Advanced Materials, vol. 25, no. 28, pp. 3780-3801. https://doi.org/10.1002/adma.201301210
Wang C, Zhang M, Mao X, Yu Y, Wang CX, Yang YL. Nanomaterials for reducing amyloid cytotoxicity. Advanced Materials. 2013 Jul 26;25(28):3780-3801. https://doi.org/10.1002/adma.201301210
Wang, Chen ; Zhang, Min ; Mao, Xiaobo ; Yu, Yue ; Wang, Chen Xuan ; Yang, Yan Lian. / Nanomaterials for reducing amyloid cytotoxicity. In: Advanced Materials. 2013 ; Vol. 25, No. 28. pp. 3780-3801.
@article{9668195cc48548299e50005e347bfb9d,
title = "Nanomaterials for reducing amyloid cytotoxicity",
abstract = "This review is intended to reflect the recent progress on therapeutic applications of nanomaterials in amyloid diseases. The progress on anti-amyloid functions of various nanomaterials including inorganic nanoparticles, polymeric nanoparticles, carbon nanomaterials and biomolecular aggregates, is reviewed and discussed. The main functionalization strategies for general nanoparticle modifications are reviewed for potential applications of targeted therapeutics. The interaction mechanisms between amyloid peptides and nanomaterials are discussed from the perspectives of dominant interactions and kinetics. The encapsulation of anti-amyloid drugs, targeted drug delivery, controlled drug release and drug delivery crossing blood brain barrier by application of nanomaterials would also improve the therapeutics of amyloid diseases. This review highlights the recent progress on therapeutic applications of nanomaterials in amyloid diseases. Nanomaterials as potential anti-amyloid drugs and drug delivery systems for currently available molecules are reviewed and the interaction mechanism between amyloid peptides and various nanomaterials is also discussed.",
keywords = "aggregation, amyloid, cytotoxicity, inhibitor, nanomaterials",
author = "Chen Wang and Min Zhang and Xiaobo Mao and Yue Yu and Wang, {Chen Xuan} and Yang, {Yan Lian}",
year = "2013",
month = "7",
day = "26",
doi = "10.1002/adma.201301210",
language = "English (US)",
volume = "25",
pages = "3780--3801",
journal = "Advanced Materials",
issn = "0935-9648",
publisher = "Wiley-VCH Verlag",
number = "28",

}

TY - JOUR

T1 - Nanomaterials for reducing amyloid cytotoxicity

AU - Wang, Chen

AU - Zhang, Min

AU - Mao, Xiaobo

AU - Yu, Yue

AU - Wang, Chen Xuan

AU - Yang, Yan Lian

PY - 2013/7/26

Y1 - 2013/7/26

N2 - This review is intended to reflect the recent progress on therapeutic applications of nanomaterials in amyloid diseases. The progress on anti-amyloid functions of various nanomaterials including inorganic nanoparticles, polymeric nanoparticles, carbon nanomaterials and biomolecular aggregates, is reviewed and discussed. The main functionalization strategies for general nanoparticle modifications are reviewed for potential applications of targeted therapeutics. The interaction mechanisms between amyloid peptides and nanomaterials are discussed from the perspectives of dominant interactions and kinetics. The encapsulation of anti-amyloid drugs, targeted drug delivery, controlled drug release and drug delivery crossing blood brain barrier by application of nanomaterials would also improve the therapeutics of amyloid diseases. This review highlights the recent progress on therapeutic applications of nanomaterials in amyloid diseases. Nanomaterials as potential anti-amyloid drugs and drug delivery systems for currently available molecules are reviewed and the interaction mechanism between amyloid peptides and various nanomaterials is also discussed.

AB - This review is intended to reflect the recent progress on therapeutic applications of nanomaterials in amyloid diseases. The progress on anti-amyloid functions of various nanomaterials including inorganic nanoparticles, polymeric nanoparticles, carbon nanomaterials and biomolecular aggregates, is reviewed and discussed. The main functionalization strategies for general nanoparticle modifications are reviewed for potential applications of targeted therapeutics. The interaction mechanisms between amyloid peptides and nanomaterials are discussed from the perspectives of dominant interactions and kinetics. The encapsulation of anti-amyloid drugs, targeted drug delivery, controlled drug release and drug delivery crossing blood brain barrier by application of nanomaterials would also improve the therapeutics of amyloid diseases. This review highlights the recent progress on therapeutic applications of nanomaterials in amyloid diseases. Nanomaterials as potential anti-amyloid drugs and drug delivery systems for currently available molecules are reviewed and the interaction mechanism between amyloid peptides and various nanomaterials is also discussed.

KW - aggregation

KW - amyloid

KW - cytotoxicity

KW - inhibitor

KW - nanomaterials

UR - http://www.scopus.com/inward/record.url?scp=84880626988&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880626988&partnerID=8YFLogxK

U2 - 10.1002/adma.201301210

DO - 10.1002/adma.201301210

M3 - Review article

C2 - 23722464

AN - SCOPUS:84880626988

VL - 25

SP - 3780

EP - 3801

JO - Advanced Materials

JF - Advanced Materials

SN - 0935-9648

IS - 28

ER -